Insider Trading Alert - BLK, WBMD And CIM Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Aug. 18, 2014, 105 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $81.56 to $73,500,000,000.00.

Highlighted Stocks Traded by Insiders:

BlackRock (BLK) - FREE Research Report

McCombe Mark, who is Senior Managing Director at BlackRock, sold 3,500 shares at $314.00 on Aug. 18, 2014. Following this transaction, the Senior Managing Director owned 33,364 shares meaning that the stake was reduced by 9.49% with the 3,500-share transaction.

The shares most recently traded at $320.08, up $6.08, or 1.9% since the insider transaction. Historical insider transactions for BlackRock go as follows:

  • 4-Week # shares sold: 600
  • 12-Week # shares sold: 600
  • 24-Week # shares sold: 10,067

The average volume for BlackRock has been 538,800 shares per day over the past 30 days. BlackRock has a market cap of $52.3 billion and is part of the financial sector and financial services industry. Shares are up 1.03% year-to-date as of the close of trading on Monday.

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors. The stock currently has a dividend yield of 2.45%. The company has a P/E ratio of 17.3. Currently, there are 8 analysts who rate BlackRock a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BLK - FREE

TheStreet Quant Ratings rates BlackRock as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, growth in earnings per share, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full BlackRock Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

WebMD Health (WBMD) - FREE Research Report

Manning James V, who is Director at WebMD Health, sold 28,200 shares at $48.53 on Aug. 18, 2014. Following this transaction, the Director owned 153,354 shares meaning that the stake was reduced by 15.53% with the 28,200-share transaction.

The shares most recently traded at $49.57, up $1.04, or 2.11% since the insider transaction. Historical insider transactions for WebMD Health go as follows:

  • 4-Week # shares sold: 113,239
  • 12-Week # shares sold: 113,239
  • 24-Week # shares sold: 113,239

The average volume for WebMD Health has been 564,100 shares per day over the past 30 days. WebMD Health has a market cap of $1.9 billion and is part of the technology sector and computer software & services industry. Shares are up 24.71% year-to-date as of the close of trading on Monday.

WebMD Health Corp. provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the United States. The company has a P/E ratio of 71.0. Currently, there are 4 analysts who rate WebMD Health a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WBMD - FREE

TheStreet Quant Ratings rates WebMD Health as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full WebMD Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Chimera Investment (CIM) - FREE Research Report

Dyer William B., who is Head of Underwriting at Chimera Investment, bought 15,000 shares at $3.24 on Aug. 18, 2014. Following this transaction, the Head of Underwriting owned 114,649 shares meaning that the stake was boosted by 15.05% with the 15,000-share transaction.

The shares most recently traded at $3.26, up $0.02, or 0.61% since the insider transaction. Historical insider transactions for Chimera Investment go as follows:

  • 4-Week # shares bought: 130,000
  • 12-Week # shares bought: 130,000
  • 24-Week # shares bought: 130,000

The average volume for Chimera Investment has been 5.2 million shares per day over the past 30 days. Chimera Investment has a market cap of $3.3 billion and is part of the financial sector and real estate industry. Shares are up 4.84% year-to-date as of the close of trading on Monday.

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The stock currently has a dividend yield of 11.08%. The company has a P/E ratio of 9.8. Currently, there are no analysts who rate Chimera Investment a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CIM - FREE

TheStreet Quant Ratings rates Chimera Investment as a hold. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, expanding profit margins and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Chimera Investment Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Asia Markets Fall on Latest Tariff Threats From Trump

Asia Markets Fall on Latest Tariff Threats From Trump

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Dow Drops Over 100 Points on Trade War Worries

Dow Drops Over 100 Points on Trade War Worries